OI Ljubljana

Programs and Projects supported by the Slovenian Research Agency

The majority of researches carried out at the Institute are supported financially by the Slovenian Research Agency (ARRS). Comprehensive studies are carried out within research programs and targeted studies within research projects.

Research programs

CodeProgramme titlePeriodPrincipal Investigator at the Insitute of Oncology
P3-0003 Development and evaluation of new approaches to cancer treatment 1. 1.2015-31. 12. 2020Acad. Prof. Gregor Sersa PhD
P3-0289 Characteristics of malignant neoplasms important for diagnosis, prognosis and treatment outcome 1. 7. 2004 - 31.12.2024Prof. Nikola Besic PhD
P3-0307 Cancer of the head and neck - analysis of biological characteristics and an attempt to improve treatment results 1. 1. 2019-31. 12. 2024Prof. Primoz Strojan PhD
P3-0321 Prognostic and predictive factors for response in treatment of different types of cancer 1. 1. 2020-31. 12. 2025Prof. Janja Ocvirk
P3-0352 Moderate and high cancer risk population: counseling, mutational screening and prevention strategies 1. 1. 2009-31. 12. 2023Prof. Janez Zgajnar PhD
P1-0389 Medical physics 1. 1. 2015-31. 12. 2020Assist. Bozidar Casar, BSc

Research projects

CodeProject titlePeriodPrincipal Investigator at the Insitute of Oncology
N3-0059 Plasma-assisted wound treatment and topical introduction of molecules 1. 1. 2017- 31. 12. 2020Acad. Prof. Gregor Sersa PhD
V3-1638 Development and implementation of personalised breast cancer risk evaluation tool for Slovenian population 1. 10. 2016-30. 9. 2019Assoc. Prof. Vesna Zadnik PhD
V3-1713 Comprehensive analysis of management of urological cancer patients with an assessment of possible delays in referrals, realization of diagnostics procedures and first treatment 2018 - 2020Assoc. Prof. Vesna Zadnik
V3-1718 Health risk assessment for exposures of children to low-frequency electric and magnetic (EM) fields in Slovenia 2018 - 2021Prof. Tadej Kotnik, Assoc. Prof. Vesna Zadnik (Institut of Oncology)
V3-1720 Analysis and estimation of requirements of human resources for cancer treatment in Slovenia 2018 - 2020Prof. Branko Zakotnik
J3-1753 Molecular predictors of radiation treatment response in breast cancer 1. 7. 2019-30. 6. 2022Asst. Prof. Katja Goricar, Asst. Prof. Tanja Marinko
J3-1760 The role of imaging and laboratory markers in the evaluation of nature and growth of thyroid nodules 1. 7. 2019-30. 6. 2022Prof. Katja Zaletel / Prof. Nikola Besic
Z3-1871 Combination of electrochemotherapy with poly (adenosin diphosphate-ribose) polymerase inhibitor in treatment of breast cancer 1. 7. 2019-30. 6. 2021Masa Bosnjak, PhD
Z3-1873 A novel vascular targeted approach based on gene therapy silencing two independent signaling pathways in combination with radiotherapy 1. 7. 2019-30. 6. 2021Monika Savarin, PhD
V3-1906 Pilot study on individualized integrated rehabilitation of breast cancer patients 2019-2022 1. 11. 2019-31. 10. 2022Prof. Nikola Besic
V3-1907 Development of indicators and methodology for monitoring the late effects of cancer treatment in childhood at national level 1. 11. 2019-31. 10. 2021Assoc. Prof. Vesna Zadnik
J1-8140 Endocrine disrupting and genotoxic potential of protein kinase inhibitors: relevance for environmental hazard 2017-2020Prof. Maja Čemažar
J3-8202 Time-lapse intra-vital imaging of immune response after electrochemotherapy induced in situ vaccination and interleukin-12 gene therapy boost 2017-2020Asst. Prof. Boštjan Šeruga, Prof. Maja Čemažar
L3-8203 Serum, genetic and epigenetic markers of risk for developing, progress and treatment response in asbestos related diseases 2017-2020Assoc. Prof.. Viljem Kovač
Z3-8204 Involvement of cytosolic DNA sensors in irradiation induced bystander and abscopal effect 1. 4. 2018 - 31. 3. 2020Jesenko Tanja
J3-8210 Potential of low, sub-therapeutic doses of statins and sartans in primary and secondary cardiovascular disease prevention 2017-2020Sr. Res. Fell. Srdjan Novaković
J4-8227 Cathepsin X inhibitors impair the resistence of tumor cells to antiprotease therapy 2017-2020Acad. Prof. Gregor Serša
J2-9225 Non-invasive technique for Cell Membrane Permeabilization using pulsed electromagnetic fields 1. 7. 2018 - 30. 6. 2021Prof. Damijan Miklavčič / Acad. Prof. Gregor Serša
J3-9269 Clinico-pharmacological approach to optimize the therapeutic bleomycin concentration in patients undergoing electrochemotherapy 1. 7. 2018 - 30. 6. 2021Acad. Prof. Gregor Serša
J5-9336 Opportunities and dangers of online health communities for healthcare 2018-2021Asst. Prof. Rok Petrič

Infrastructure programs

CodeProgramme titlePeriodPrincipal Investigator at the Insitute of Oncology
IP-0302 Lifelong Follow-Up of Survivors of Childhood and Adolescent Cancer and Related Translational Trials 2009-2020Asst. Prof. Lorna Zadravec Zaletel PhD

Completed research projects

CodeProject titlePeriodPrincipal Investigator at the Insitute of Oncology
LEA-EBAM- Pulsed Electric Fields Applications in Biology and Medicine acad. prof. Gregor Sersa PhD
DIETINT- A randomized phase II study for tertiary prevention of squamocellular cancer of head and neck (SCCHN) with a dietary intervention 2015-2019Prof. Primož Strojan PhD
COST- Cancer and Work Network (CANWON): ISCH COST Action IS1211 Assoc. Prof. Vesna Zadnik PhD
HIGHCARE- High resolution project on prognosis and care of cancer patients 2016-2019Maja Primic Žakelj PhD, Vesna Zadnik PhD
BI-AT/18-19-003- Cancer stem cell (CSC)-associated exosomes as regulators of tumor radiation response 2018-2019Prof. Maja Čemažar PhD
V3-1638 Development and implementation of personalised breast cancer risk evaluation tool for Slovenian population 1. 10. 2016-30. 9. 2019Assoc. Prof. Vesna Zadnik PhD
J3-7272 Methods of estimation of key indicators in population cancer survival 2016 - 2018Maja Primic Zakelj PhD, Assoc. Prof. Vesna Zadnik
J3-7372 Molecular biomarkers and biomarker-driven therapy in lung cancer 2016-2018Prof. Tanja Čufer, Assoc. Prof. Viljem Kovač
J3-7460 Irradiation dose modifying factor of squamous cell carcinoma of the oropharynx infected by human papillomavirus: an in vitro and in vivo study in laboratory mouse tumor model 1.1.2016 - 31.12.2018Prof. Primož Strojan
J3-7494 Tunneling nanotubes for innovative urinary bladder cancer treatment 2016-2018Prof. Maja Cemazar PhD
L2-7550 Electrospun nanofibrous materials for solid state drug delivery system 1.3.2016 - 28.2.2019Prof. Igor Emri



© 2019 - Institute of Oncology Ljubljana
color contrast
text size
highlighting content
zoom in